| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0749-0704(05)70396-1 |
| P698 | PubMed publication ID | 9561818 |
| P2093 | author name string | Quintiliani R | |
| Nightingale CH | |||
| Owens RC Jr | |||
| Cunha BA | |||
| Crowe HM | |||
| Ambrose PG | |||
| Yeston N | |||
| P2860 | cites work | Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa | Q35120290 |
| Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis | Q35810298 | ||
| Infectious complications of indwelling vascular catheters | Q35810936 | ||
| Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients | Q35814807 | ||
| Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones | Q36901924 | ||
| Once-daily aminoglycoside therapy | Q37730823 | ||
| From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever | Q37906806 | ||
| Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 | ||
| Fungicidal effect of amphotericin B in urine: in vitro study to assess feasibility of bladder washout for localization of site of candiduria | Q40087389 | ||
| Bactericidal Activity of Cephalosporins in an In Vitro Model Simulating Serum Levels | Q40618786 | ||
| New approaches in the diagnosis of nosocomial pneumonia. | Q40698531 | ||
| Clinical use of liposomal and lipid-complexed amphotericin B. | Q40705427 | ||
| Drug fever. The importance of recognition | Q40804862 | ||
| Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units | Q41072205 | ||
| The evolution of resistance to cephalosporins | Q41440920 | ||
| Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. | Q43482879 | ||
| Choosing between the new cephalosporin antibiotics: a pharmacodynamic approach | Q43501310 | ||
| Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole | Q43543160 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients | Q44769923 | ||
| Infections in liver transplant recipients | Q70971228 | ||
| Community-acquired pneumonia | Q71523501 | ||
| Lack of toxicity of long-term, high total dose liposomal amphotericin B | Q72428384 | ||
| A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute | Q72741418 | ||
| Consequences of intravascular catheter sepsis | Q72826809 | ||
| P433 | issue | 2 | |
| P921 | main subject | antibiotic | Q12187 |
| P304 | page(s) | 283-308 | |
| P577 | publication date | 1998-04-01 | |
| P1433 | published in | Critical Care Clinics | Q15757467 |
| P1476 | title | Antibiotic use in the critical care unit | |
| P478 | volume | 14 |
Search more.